Navigation Links
XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Date:8/19/2007

p> Interim Consolidated Statements of Cash Flows

for the Six Months Ended June 30, 2007 and 2006 (unaudited)

(in thousands of US dollars)

Period from

Six months March 9, 1993(*)

ended June 30, to June 30,

2007 2006 2007

---------- ---------- ----------

CASH FLOWS FROM OPERATING ACTIVITIES:

Loss for the period (14,649) (7,291) (129,572)

Adjustments to reconcile loss to net cash

used in operating activities:

Depreciation and amortization 69 114 3,141

Linkage difference on restricted long-term (2) (4) (9)

deposits

Acquisition of in process research

and development -- -- 1,783

Gain on disposal of property and equipment (53) (25) (92)

Increase (decrease) in liability in

respect of employee severance obligations (49) 35 1,187

Impairment charges 95 -- 475

Gain from sales of investment securities -- -- (410)

Other income related to exchange of shares -- -- (100)

Loss from trading securities 48 -- 46

Stock option based compensation expenses 969 1,213 6,427

Stock appreciation rights compensation

expenses 565 -- 565

Gain on amounts funded in respect of

employee severance pay funds -- -- (92)

Deferred tax asset 48 -- --

Changes
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... neutral. That is, most of the atoms in ... electrons in the outer parts of atoms equals the ... As one or more electrons are plucked away from ... positive pull from the nucleus. This enhanced pull, ... those electrons are less vulnerable to the distractions of ...
(Date:7/18/2014)... July 18, 2014 Global biotechnology ... US offices in Cambridge, MA, announces the launch ... and Software product that leverages the power of ... Illumina® MiSeq sequencing platform. The assay and software ... Hospital of Philadelphia (CHOP) and will include a ...
(Date:7/18/2014)... 18, 2014 The International Wheat Genome Sequencing ... a draft sequence of the bread wheat genome. The ... and evolution of the large, complex genome of the ... genetic blueprint is an invaluable resource to plant science ... at their disposal a set of tools enabling them ...
(Date:7/17/2014)... 17, 2014  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... development and commercialization of products for the treatment of ... results for the second quarter of 2014 on Thursday, ... The Company will host a conference call at ... which Vanda management will discuss the second quarter 2014 ...
Breaking Biology Technology:Highly charged ions 2Highly charged ions 3Highly charged ions 4Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3Genetic Blueprint of Bread Wheat Genome Unveiled 2Genetic Blueprint of Bread Wheat Genome Unveiled 3Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2
... NPSP ) announced today that it has commenced,a ... outstanding 3.0% Convertible,Notes due 2008. The tender offer will ... extended. The tender offer, which is described,fully in an ... is not,subject to the receipt of any minimum amount ...
... BSX ) today announced that the Company,s Board ... Mr. Elliott, 58, is Chairman of the Board of ... Chief Executive Officer of,Zimmer from 2001 to 2007 and ... and director experience in medical devices,orthopaedics and other industries. ...
... 6 Resource Optimization &,Innovation (ROi), a ... Sisters of Mercy Health System, has signed ... purchasing Elekta,s innovative cancer treatment,solutions. (Logo: ... agreement, Mercy will offer its members the ...
Cached Biology Technology:NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 2NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 3NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 4Boston Scientific Announces Election of Ray Elliott to Its Board of Directors 2Boston Scientific Announces Election of Ray Elliott to Its Board of Directors 3Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions 2
(Date:7/21/2014)... A new study in mice reveals that mesenchymal ... resistance exercise. , By injecting MSCs into mouse ... (similar to the lengthening contractions performed during resistance training ... were able to increase the rate of repair and ... the exercising mice. , The findings, described in ...
(Date:7/21/2014)... full of high-fat foods cause you to lose your ... State University neuroscientists says so, and it has researchers ... impact a whole range of human functions that were ... , "This opens up a lot of possibilities for ... Thiebaud, who led the study examining how high-fat foods ...
(Date:7/21/2014)... Growers of annual bedding plant seedlings or plugs ... a large stem diameter and high root dry ... during shipping and transplant. To achieve these desirable ... on supplemental lighting from high-pressure sodium lamps during ... diodes (LEDs) can give greenhouse growers other lighting ...
Breaking Biology News(10 mins):Stem cells aid muscle repair and strengthening after resistance exercise 2New research links bad diet to loss of smell 2LEDs shine in bedding plant production study 2
... Oct. 1, 2013  Pfenex Inc. today announced that the ... Biomedical Advanced Research and Development Authority (BARDA), has modified ... with the existing Pfenex contractual relationship begun in July, ... funding to support the development of a next generation ...
... October 1, 2013 -- Resveratrol, a naturally occurring polyphenol ... peanuts, and found in red wine, has been touted ... antioxidant properties. This has been supported by some experimental ... new study using two multiple sclerosis (MS) models published ...
... , Sept. 30, 2013 /PRNewswire-iReach/ -- Clinilabs, a ... drug development services to industry, announced today that they ... an investigational medication for Type 2 Diabetes Mellitus.  The ... tolerability of multiple daily doses of the investigational medication ...
Cached Biology News:Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine 2Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 2Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 3Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication 2
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... H2OBIT is a fully licensed, high throughput, water ... of up to 24 microplates. This equates to ... ,A robotic arm rapidly transfers a basket ... temperature ramping times that are considerably faster than ...
... used gasketed gel trays. Turn the tray 90 degrees ... back and run the gel - its as simple ... tray is UV transparent. Each tray accommodates two comb ... one in the center. This allows you the option ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: